1. British Pharmacopoeia (2019) Vol. 1. Medicines and Healthcare Products Regulatory Agency, London
2. The United States Pharmacopeia and National Formulary (2016) The official compendia of standards, Asian Edition, USP 39-NF34 The United States Pharmacopeial Conversion Inc., Rockvill, MD
3. Ong CKS, Lirk P, Tan CH, Seymour RA (2007) An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res 5:19–34
4. Howard PA, Delafontaine P (2004) Nonsteroidal anti-inflammatory drugs and cardiovascular risk. J Am Coll Cardiol 43:519–525
5. Ali H, Nawab A, Farooq N, Ashraf I, Sodagar M, Tariq A, Naqvi GR (2018) Celecoxib as an effective Cox-2 inhibitor for rheumatologic disorders: efficacy and safety concerns. AJSMU 4(1):51–56